Top Markets
#1 Black Phoenix Black Phoenix +829.16%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.44%
#3 Not in Employment, Education, or Training Not in Employment, Education, or Training +23.87%
#4 Beam Beam +22.86%
#5 SAFEcoin SAFEcoin +20.79%
#6 pipedog pipedog +19.54%
#7 Magma Finance Magma Finance +19.01%
#8 Official Trump Official Trump +16.95%
#9 PondCoin PondCoin +16.74%
#10 Bless Bless +16.26%
Coin of the day
Black Phoenix Black Phoenix
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Kailera Therapeutics, Inc. Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc.

KLRA
Pozycja w akcjach #5856
Kailera Therapeutics is a biopharmaceutical company currently advancing through... Kailera Therapeutics is a biopharmaceutical company currently advancing through its clinical development stage, dedicated to cultivating a varied portfolio of cutting-edge treatments. These therapeutics are specifically engineered to tackle obesity and its associated metabolic disorders. The company distinguishes itself through its focus on innovative methodologies, offering both injectable and orally administered formulations for sustainable weight management. Its most advanced candidate is a groundbreaking dual-action gut hormone receptor agonist, which has reported encouraging outcomes in its initial clinical investigations.
Cena akcji
$18.40
Kapitalizacja rynkowa
$2.38B
Zmiana (1 dzień)
-0.22%
Zmiana (1 rok)
-
Kraj
US
Handel Kailera Therapeutics, Inc. (KLRA)

Kategoria

Healthcare
Zyski dla Kailera Therapeutics, Inc. (KLRA)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Kailera Therapeutics, Inc., obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Kailera Therapeutics, Inc. od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH